Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
European Journal of Haematology
|
January 19, 2023
Desmopressin as a hemostatic and blood sparing agent in bleeding disorders
Ajay Mohinani, Sarah Patel, Virginia Tan, et al.
Journal of Thrombosis and Thrombolysis
|
March 5, 2025
Unveiling the complexities of catheter-related thrombosis: risk factors, preventive strategies, and management
Hannah L King, Thalia Padilla-Lazos, Akshit Chitkara, et al.
Integrative and Comparative Biology
|
June 18, 2014
A lack of crowding? Body size does not decrease with density for two behavior-manipulating parasites
Kelly L Weinersmith, Chloe B Warinner, Virginia Tan, et al.
Cytotherapy
|
February 20, 2026
Impact of ABO compatibility on outcomes after allogeneic hematopoietic cell transplantation (HCT): increased risk of acute GVHD with ABO bidirectional mismatch, independent of traditional and emerging GVHD prophylaxis strategies
Yun Yu, Mikayla K Murphy, Virginia Tan, et al.
European Journal of Haematology
|
July 12, 2024
The impact of hematology electronic consultations on the management of iron deficiency
Hannah L King, Genevieve B Benedetti, Stefan Barisic, et al.
Blood Neoplasia
|
August 12, 2025
Real-world performance of the CALGB 10403 regimen in young adults in the United States
Brandon DaSilva, Alicia Darwin, Amy Zhang, et al.
Transplantation and Cellular Therapy
|
June 27, 2026
Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)
Rawan G Faramand, Amy Zhang, Gregory W Roloff, et al.
Blood Advances
|
June 25, 2026
Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL
Tamer Othman, Gregory W Roloff, Katharine Miller, et al.
Blood Advances
|
October 6, 2025
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia
Yannis K Valtis, Chenyu Lin, David Nemirovsky, et al.
Blood
|
February 5, 2026
Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene
Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
European Journal of Haematology
|
January 19, 2023
Desmopressin as a hemostatic and blood sparing agent in bleeding disorders
Ajay Mohinani, Sarah Patel, Virginia Tan, et al.
Journal of Thrombosis and Thrombolysis
|
March 5, 2025
Unveiling the complexities of catheter-related thrombosis: risk factors, preventive strategies, and management
Hannah L King, Thalia Padilla-Lazos, Akshit Chitkara, et al.
Integrative and Comparative Biology
|
June 18, 2014
A lack of crowding? Body size does not decrease with density for two behavior-manipulating parasites
Kelly L Weinersmith, Chloe B Warinner, Virginia Tan, et al.
Cytotherapy
|
February 20, 2026
Impact of ABO compatibility on outcomes after allogeneic hematopoietic cell transplantation (HCT): increased risk of acute GVHD with ABO bidirectional mismatch, independent of traditional and emerging GVHD prophylaxis strategies
Yun Yu, Mikayla K Murphy, Virginia Tan, et al.
European Journal of Haematology
|
July 12, 2024
The impact of hematology electronic consultations on the management of iron deficiency
Hannah L King, Genevieve B Benedetti, Stefan Barisic, et al.
Blood Neoplasia
|
August 12, 2025
Real-world performance of the CALGB 10403 regimen in young adults in the United States
Brandon DaSilva, Alicia Darwin, Amy Zhang, et al.
Transplantation and Cellular Therapy
|
June 27, 2026
Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)
Rawan G Faramand, Amy Zhang, Gregory W Roloff, et al.
Blood Advances
|
June 25, 2026
Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL
Tamer Othman, Gregory W Roloff, Katharine Miller, et al.
Blood Advances
|
October 6, 2025
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia
Yannis K Valtis, Chenyu Lin, David Nemirovsky, et al.
Blood
|
February 5, 2026
Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene
Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang, et al.
Page
of 1